← Leaderboards
Ira J Dunkel
St. Jude Children'S Research Hospital
$17,198,806
Attributed
$34,397,612
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,397,612 · 1
By mechanism
UM1$34,397,612 · 1
Top collaborators
- Arzu Onar-Thomas10 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- James M Boyett$5,624,863
- Arzu Onar-Thomas$18,562,079
- Richard James Gilbertson$38,555,720
- Charles W Roberts$21,463,141
- Suzanne J Baker$15,879,154
Others in their field
Top investigators on “Mission”
- Kelly K Wismer · Department Of Defense$358,750,224
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$333,898,233
- Michael E Cheney · Department Of Defense$330,315,072
- David Heimbrook · Leidos Biomedical Research, Inc.$325,587,550
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
MissionMedulloblastomaInnovationMemberLaboratory StudyChildhood Central Nervous System NeoplasmEpendymomaGenomicsImmunotherapyGliomaInstitutionLaboratoriesCancer VaccinesCentral Nervous System NeoplasmsDiffuse Intrinsic Pontine GliomaChildhood Brain NeoplasmBrain NeoplasmsChildBiologicalChildhoodBiologyCessation Of LifeClinical TrialsMonitor
Grant awards (10)
Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors$3,793,439
UM1 · FY2025 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.$3,704,144
UM1 · FY2024 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.$3,361,716
UM1 · FY2023 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.$3,440,662
UM1 · FY2022 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.$4,353,842
UM1 · FY2021 · CA
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.$4,810,822
UM1 · FY2020 · CA
Pediatric Brain Tumor Consortium (PBTC)$2,781,436
UM1 · FY2019 · CA
Pediatric Brain Tumor Consortium (PBTC)$2,711,850
UM1 · FY2018 · CA
Pediatric Brain Tumor Consortium (PBTC)$2,728,300
UM1 · FY2017 · CA
Pediatric Brain Tumor Consortium (PBTC)$2,711,401
UM1 · FY2016 · CA